The DHT:Testosterone Ratio That Predicts Hair Loss on TRT

Most men start testosterone replacement therapy to feel stronger, sharper, and more like themselves again - but nobody signs up expecting to watch their hairline move. Yet for a significant subset of men on TRT, that is exactly what happens, and understanding why requires looking past total testosterone levels to a ratio that many clinicians consider far more revealing.

Why One Hormone Number Tells Only Half the Story

Testosterone gets most of the attention in men's health conversations, and for good reason. It influences muscle mass, mood, libido, energy, and dozens of other functions. But testosterone is also a precursor - a starting material that your body converts into other hormones, and one of the most potent of those downstream products is dihydrotestosterone, commonly called DHT.

DHT is made through a process called 5-alpha reduction. An enzyme called 5-alpha reductase binds to testosterone and converts it into DHT, which is structurally similar but significantly more androgenic - meaning it binds to androgen receptors more tightly and for longer than testosterone does. This makes DHT a much stronger signal at the receptor level, and at hair follicles in genetically susceptible men, that signal can be devastating.

Looking at testosterone alone is a bit like checking the speed of a river without noticing how much water is actually spilling over the banks. The DHT:testosterone ratio captures something that a single testosterone number cannot: how aggressively your body is converting available testosterone into its more potent form.

The Biology of a Shrinking Follicle

To understand why the ratio matters for hair, you first need to understand what DHT actually does to a follicle.

Hair grows in cycles. There is an active growth phase called anagen, a transitional phase called catagen, and a resting phase called telogen, after which the hair sheds and the cycle restarts. In healthy follicles, the anagen phase can last several years, producing long, thick, pigmented strands.

In men with androgenetic alopecia - the pattern baldness that runs in families - genetically sensitive follicles on the scalp react to DHT by gradually miniaturizing. Each cycle, the anagen phase gets a little shorter. The follicle produces a thinner, lighter, shorter hair. Over time, the follicle shrinks to the point where it produces nearly nothing at all. This process is slow and cumulative, which is why hair loss often seems to creep up on men before they notice it has become significant.

DHT is not the only factor in this equation, but it is the central hormonal signal driving miniaturization in susceptible follicles. The follicles at the temples and crown tend to carry more androgen receptors and respond most intensely to DHT, which is why male pattern hair loss follows predictable patterns.

Why TRT Reshapes Your Hormonal Environment

When a man begins testosterone replacement therapy, he is introducing exogenous testosterone into a system that will process it according to its own enzymatic tendencies. That means some of the additional testosterone will inevitably be converted to DHT, and how much depends on a range of factors.

The route of administration matters. Different delivery methods - injections, gels, creams, patches, pellets - create different concentration patterns over time. Some routes produce higher peaks and steeper troughs in testosterone levels, which can influence how much conversion to DHT occurs. Others maintain steadier levels. Individual metabolic responses to each route also vary considerably.

Beyond route, the activity of 5-alpha reductase varies from person to person and is influenced by genetics, age, body composition, and even the microenvironment of the scalp itself. Two men on identical TRT protocols can end up with meaningfully different DHT levels simply because one converts testosterone more aggressively than the other.

This variability is precisely why the DHT:testosterone ratio can be more informative than either number in isolation. A man with a high total testosterone but a low ratio may be converting relatively little of it to DHT. A man with a moderate total testosterone but a high ratio may actually be producing more DHT than someone with higher testosterone overall. That distinction has real implications for hair follicles.

What a Higher Ratio Actually Implies - and What It Does Not

A higher DHT:testosterone ratio suggests that a greater proportion of circulating testosterone is being converted into its more potent form. For men who are genetically predisposed to androgenetic alopecia, this can accelerate the miniaturization process that was already underway or waiting in the wings.

But it is critical to be honest about what this ratio can and cannot tell you. There is no universal threshold above which hair loss is certain and below which it is safe. The ratio is a clue, not a verdict. A man with a high ratio and no family history of hair loss, few androgen receptors in his scalp follicles, and a naturally resilient hormonal environment may never experience significant thinning. Meanwhile, a man with a moderate ratio but strong genetic predisposition and high androgen receptor sensitivity may lose hair more rapidly.

The ratio also does not capture local DHT production in the scalp. Some of the DHT acting on follicles is produced right there in the scalp tissue itself, not just delivered via circulation. Scalp 5-alpha reductase activity can be elevated in men with androgenetic alopecia independently of what systemic blood tests show. This is why two men with similar serum ratios can have very different scalp-level DHT exposure.

Think of the ratio as one piece of a larger diagnostic picture rather than a standalone predictor.

Why Some Men on TRT Lose Hair and Others Do Not

Genetics is the dominant variable. If your father, maternal grandfather, and uncles all had significant hair loss, your androgen receptors are likely more sensitive to DHT, and your follicles are more vulnerable to its miniaturizing effects. TRT does not cause androgenetic alopecia in men who have no genetic predisposition - it can only accelerate a process that was biologically destined to occur.

Age plays a role as well. Men who are already in the early stages of miniaturization when they start TRT may notice acceleration faster than men who begin therapy at a younger age with a full, dense baseline.

The scalp microenvironment - including local blood flow, inflammation, sebum production, and the local activity of reductase enzymes - also influences how DHT affects individual follicles. Chronic low-grade scalp inflammation, for example, can compound the follicular damage associated with DHT exposure.

Finally, individual enzyme activity determines how much testosterone gets converted to DHT in the first place. Men who are naturally high converters will produce more DHT from the same amount of testosterone, independent of anything related to their TRT protocol.

Conversations Worth Having With Your Clinician

If you are on TRT or considering it and hair loss concerns you, the conversation with your clinician should cover several areas.

Start with your personal and family history. A thorough review of your hair baseline before therapy, your family pattern on both sides, and any changes you have noticed since starting TRT gives your clinician essential context. Hair loss that began or accelerated after starting therapy is worth documenting carefully, including where on the scalp it is occurring and how quickly.

Lab work is part of the picture. Clinicians commonly look at testosterone levels in various forms - total, free, and bioavailable - as well as DHT and, often, other hormones that can influence the overall endocrine environment. No single lab value is definitive, and what matters is how your results fit your clinical picture. A clinician experienced in men's hormonal health will interpret these numbers in context, not in isolation.

Scalp changes are worth monitoring actively. If you are noticing increased shedding, thinning at the temples or crown, or a change in hair texture or density, those observations are clinically relevant and should be communicated, not minimized.

Strategies Clinicians May Consider When Hair Is a Concern

The good news is that hair concerns on TRT are not necessarily a reason to abandon therapy. There are several directions a clinician may explore, and none of them require simply accepting the hair loss as inevitable.

Adjusting the TRT approach is sometimes worth evaluating. Changes in delivery method or protocol timing can influence how the body processes testosterone and, by extension, how much DHT is produced. Whether any adjustment is appropriate depends entirely on the individual's clinical goals and health profile.

Medication classes that work by reducing 5-alpha reductase activity exist and are commonly used for hair preservation. These medications reduce the conversion of testosterone to DHT, which can slow or halt miniaturization in many men. They are not without trade-offs - some men experience changes in libido, mood, or sexual function, and these side effects, though not universal, are real and worth discussing honestly with a provider. The decision to use any of these medications should be made with full awareness of both the potential benefits and the risks.

Topical therapies are another avenue. Certain topically applied treatments work locally at the scalp level to support follicle health and circulation. Some clinicians also consider topical forms of DHT-reducing agents that may have lower systemic impact than oral versions, though individual responses vary.

Contributing factors should also be addressed. Nutritional status, sleep quality, stress levels, and metabolic health all influence hair cycling and follicle resilience. A comprehensive approach looks at the full picture rather than treating hair loss as an isolated hormonal problem.

Self-medicating with supplements or medications sourced outside a clinical relationship is a risk worth naming directly. Some men turn to over-the-counter or gray-market options to manage hair loss on TRT, which removes the clinical oversight that keeps these interventions safe. Any intervention that affects your hormonal environment carries risks and should be supervised.

The Ratio Is a Clue, Not a Sentence

The DHT:testosterone ratio is a genuinely useful piece of information for men navigating TRT and hair concerns. It captures something meaningful about how your body processes testosterone and gives clinicians a richer picture than any single number can provide. But ratios exist in context. They do not override genetics, ignore individual biology, or predict outcomes with certainty.

Hair loss on TRT is not inevitable, and for men who do experience it, the situation is rarely irreversible if addressed early. The key is having the right conversation with a clinician who understands both testosterone optimization and its downstream effects - someone who will look at your full hormonal profile, your history, and your goals rather than applying a one-size-fits-all answer.

Providers like AlphaMD specialize in exactly this kind of individualized men's health care, helping patients work through the nuances of TRT, DHT, hair concerns, and everything in between with personalized medical guidance rather than generic protocols. If you are asking these questions, that is exactly where the conversation should start.